# Nuclide record idea-neoadjuvant-psma-therapy (idea). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/ideas/idea-neoadjuvant-psma-therapy/>
  a schema:CreativeWork ;
  nuclide:kind "idea" ;
  schema:identifier "idea-neoadjuvant-psma-therapy" ;
  schema:name "Neoadjuvant PSMA radioligand therapy before prostatectomy"@en ;
  schema:description "For men with high-risk prostate cancer that hasn't spread yet, giving a dose or two of PSMA-targeted radioactive treatment before surgery, rather than only using it after the cancer has spread, might kill hidden cancer cells surgery alone would miss. It is still experimental and hasn't yet been shown to help patients live longer or avoid the cancer coming back."@en ;
  schema:url <https://nuclide.cc/ideas/idea-neoadjuvant-psma-therapy/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/37891072/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC12563130/>, <https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-04728> ;
  nuclide:tag "neoadjuvant", "prostate", "surgery" ;
  nuclide:related <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/indications/prostate-high-risk/>, <https://nuclide.cc/terms/prostatectomy/>, <https://nuclide.cc/ideas/idea-psma-pet-guided-mdt/>, <https://nuclide.cc/isotopes/lu-177/> .